Minxiang Lei

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study

Dalong Zhu, Shenglian Gan, Yu Liu et al. · The Lancet Diabetes & Endocrinology · 2018 · 102 citations

Medicine, Pharmacology, Pharmacotherapy +10

Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China

Weimin Wang, Qiuhe Ji, Chenxi Li et al. · Diabetes/Metabolism Research and Reviews · 2023 · 95 citations · Full text

Medicine, Internal Medicine, Diabetology +14

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: A nationwide cross-sectional study in mainland China

Chenxi Li, Weimin Wang, Qiuhe Ji et al. · Diabetes Research and Clinical Practice · 2023 · 66 citations

Medicine, Endocrinology, Neurology +10